| Long name: |
Polyclonal Antibody to Apolipoprotein A2 (APOA2) |
| Antigen: |
Apolipoprotein A2 (APOA2) |
| Other names: |
Alternative name(s):, Apolipoprotein A-II, Apolipoprotein A-II(1-76), Apolipoprotein A2Cleaved into the following chain:Truncated apolipoprotein A-II, apolipoprotein A-II, apolipoprotein A-II, apolipoprotein A2, apolipoprotein A-II preproprotein |
| Gene name: |
APOA2, Apolipoprotein A2 (APOA2) |
| Gene synonims: |
APOA2, Apo-AII, Apo-AII, ApoA-II, ApoA-II, apoAII, APOA2 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Due to limitted amount of tested species we cannot guarantee that no crossreactivity will occur |
| Specificity: |
, APOA2, It has been selected for its ability to recognize APOA2 in immunohistochemical staining andwestern blotting, The antibody is a rabbit polyclonal antibody raised against APOA2, This is an antibody designed to detect Apolipoprotein A2 (APOA2) |
| Purification method: |
This antibody was purified via Affinity Chromatography |
| Form/Appearance: |
containing 0, pH7, 02% NaN3, 4, 50% glycerol, Supplied as solution form in PBS |
| Concentration: |
2mg/ml |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, ELISA, IFA, Immunohistochemistry (IHC) - Formalin/Paraffin, Western Blot (WB), Immunocytochemistry (ICC) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
Apolipoprotein A2 (APOA2) |
| Short name: |
Anti- Apolipoprotein A2 (APOA2) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to Apolipoprotein A2 (apolipoprotein A-II) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APOA2 and IDBG-104234 and ENSG00000158874 and 336, APOA2 and IDBG-630130 and ENSBTAG00000009212 and 505394, Apo-AII and ApoA-II and apoAII, Apoa2 and IDBG-204212 and ENSMUSG00000005681 and 11807, Extracellular, high-density lipoprotein particle receptor binding, this GO :0001523 and retinoid metabolic process and biological process this GO :0002526 and acute inflammatory response and biological process this GO :0002740 and negative regulation of cytokine secretion involved in immune response and biological process this GO :0005319 and lipid transporter activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0005788 and endoplasmic reticulum lumen and cellular component this GO :0005829 and cytosol and cellular component this GO :0006457 and protein folding and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006656 and phosphatidylcholine biosynthetic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0005319 : lipid transporter activity, this GO :0005319 : lipid transporter activity and also this GO :0005515 : protein binding and also this GO :0005543 : phospholipid binding and also this GO :0008035 : high-density lipoprotein particle binding and also this GO :0008289 : lipid binding and also this GO :0015485 : cholesterol binding and also this GO :0017127 : cholesterol transporter activity and also this GO :0031210 : phosphatidylcholine binding and also this GO :0034190 : apolipoprotein receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity and also this GO :0055102 : lipase inhibitor activity and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity and also this GO :0070653 : high-density lipoprotein particle receptor binding, this GO :0005515 : protein binding, this GO :0005543 : phospholipid binding, this GO :0008035 : high-density lipoprotein particle binding, this GO :0008289 : lipid binding, this GO :0015485 : cholesterol binding, this GO :0017127 : cholesterol transporter activity, this GO :0031210 : phosphatidylcholine binding, this GO :0034190 : apolipoprotein receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, this GO :0055102 : lipase inhibitor activity, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0070653 : high-density lipoprotein particle receptor binding, visible light and biological process this GO :0008035 and high-density lipoprotein particle binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0009395 and phospholipid catabolic process and biological process this GO :0009749 and response to glucose and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010903 and negative regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0016032 and viral process and biological process this GO :0017127 and cholesterol transporter activity and molecular function this GO :0018158 and protein oxidation and biological process this GO :0018206 and peptidyl-methionine modification and biological process this GO :0030300 and regulation of intestinal cholesterol absorption and biological process this GO :0030301 and cholesterol transport and biological process this GO :0031100 and organ regeneration and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0031647 and regulation of protein stability and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034374 and low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034380 and high-density lipoprotein particle assembly and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042493 and response to drug and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043627 and response to estrogen and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045416 and positive regulation of interleukin-8 biosynthetic process and biological process this GO :0046340 and diacylglycerol catabolic process and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0050996 and positive regulation of lipid catabolic process and biological process this GO :0051384 and response to glucocorticoid and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060192 and negative regulation of lipase activity and biological process this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0060621 and negative regulation of cholesterol import and biological process this GO :0060695 and negative regulation of cholesterol transporter activity and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070653 and high-density lipoprotein particle receptor binding and molecular function this GO :0072562 and blood microparticle and cellular component, apolipoprotein A-II |
| Identity: |
601 |
| Gene: |
APOA2 |
More about : APOA2 |
| Long gene name: |
apolipoprotein A2 |
| Synonyms gene name: |
apolipoprotein A-II |
| Locus: |
1q23, 3 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
336 |
| Pubmed identfication: |
2415515 |
| RefSeq identity: |
NM_001643 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000034346 |